HBV Mutation Detail Information

> G2011A Search Result

Mutation Information

Mutation Site	G2011A
Mutation Type	Nucleotide level
Gene/Protein/Region Type	C

Literature Information

PubMed PMID	28088502
Disease	Chronic hepatitis B
Published Year	2017
Journal	Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
Title	The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological response.
Author	Peng Y,Li Y,Hou J,Sun J,Su M,Li Y,Xiang K,Yan L,Zhuang H,Li T
Evidence	The C1969T and G2011A/C were found to increase mostly from 9.6% (5/52) at baseline to 17.3% (9/52) at week 12 of treatment (P = 0.250) and from 3.8% (2/52) at baseline to (11.5%, 6/52) at week 12 of treatment (P = 0.141), respectively.

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation